首页 | 本学科首页   官方微博 | 高级检索  
     


The anti-Candida activity of Thymbra capitata essential oil: effect upon pre-formed biofilm
Authors:Palmeira-de-Oliveira A  Gaspar C  Palmeira-de-Oliveira R  Silva-Dias A  Salgueiro L  Cavaleiro C  Pina-Vaz C  Martinez-de-Oliveira J  Queiroz J A  Rodrigues A G
Affiliation:1. CICS-UBI, Health Sciences Research Center, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal;2. Department of Microbiology, Faculty of Medicine, University of Porto, Porto, Portugal;3. Cardiovascular Research &; Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal;4. Centre of Pharmaceutical Studies, Faculty of Pharmacy, University of Coimbra, Portugal;5. Women and Child Health Department, Hospital Center of Cova da Beira, Covilhã, Portugal
Abstract:

Ethopharmacological relevance

Thymbra capitata essential oil is traditionally considered to exhibit powerful antiseptic properties, thus being used to treat cutaneous infections. The aim of the present study was to evaluate the effect of Thymbra capitata essential oil upon pre-formed biofilm of different Candida strains while comparing it with the activity against planktonic cells.

Materials and methods

Fifteen Candida isolates were included, corresponding to clinical and collection type strains. Essential oil was obtained by hydrodistillation and its composition analysed by GC/MS. Activity upon planktonic cells was evaluated according to M27-A3 macromethod. Its effect upon 24 h preformed biofilm biomass was determined using the crystal violet procedure and the metabolic activity was studied applying the XTT/menadione technique.

Results

Biofilm biomass and metabolic activity of all tested species were reduced up to 50% at MIC values. The effect was more pronounced at double MIC values, achieving >80% reduction, except for Candida albicans that presented a more resistant profile (62%).

Conclusion

Thymbra capitata essential oil presented an important effect upon Candida biofilms. It is proposed as a valuable antifungal product to be used in an appropriate pharmaceutical formulation for the management of resistant mucocutaneous candidosis.
Keywords:BHI, brain heart infusion   CLSI, Clinical Laboratory Standard Institute   CV, crystal violet   DMSO, dimethyl sulfoxide   EO, essential oil   GC, gas chromatography   GC/MS, gas chromatography/mass spectrometry   MIC, minimal inhibitory concentration   MLC, minimal lethal concentration   MOPS, 3-(N-morpholino) propanesulfonic acid   RVVC, recurrent vulvovaginal candidosis   YPD, yeast potato dextrose broth   SDA, sabouraud agar   VVC, vulvovaginal candidosis   XTT, 2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号